4.7 Article

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

期刊

RADIOTHERAPY AND ONCOLOGY
卷 136, 期 -, 页码 78-85

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2019.03.032

关键词

Non-small cell lung cancer; Radiomics; Cone-beam CT; Longitudinal; Overall survival

资金

  1. ERC [694812, 81320]
  2. Dutch Technology Foundation STW the applied science division of NWO [10696, P14-19]
  3. Ministry of Economic Affairs
  4. SME [673780]
  5. EUROSTARS (DART)
  6. EUROSTARS (DECIDE)
  7. EUROSTARS (COMPACT)
  8. European Program H2020-2015-17 (BD2Decide) [PHC30-689715]
  9. European Program H2020-2015-17 (ImmunoSABR) [733008]
  10. European Program H2020-2015-17 (PREDICT - ITN) [766276]
  11. TRANSCAN Joint Transnational Call 2016 (JTC2016 CLEARLY) [UM 2017-8295]
  12. Interreg V-A Euregio MeuseRhine (Euradiomics)
  13. Health Foundation Limburg
  14. Dutch Cancer Society
  15. AgeCare (Academy of Geriatric Research at Odense University Hospital)

向作者/读者索取更多资源

Background and purpose: The prognostic value of radiomics for non-small cell lung cancer (NSCLC) patients has been investigated for images acquired prior to treatment, but no prognostic model has been developed that includes the change of radiomic features during treatment. Therefore, the aim of this study was to investigate the potential added prognostic value of a longitudinal radiomics approach using cone-beam computed tomography (CBCT) for NSCLC patients. Materials and methods: This retrospective study includes a training dataset of 141 stage I-IV NSCLC patients and three external validation datasets of 94, 61 and 41 patients, all treated with curative intended (chemo) radiotherapy. The change of radiomic features extracted from CBCT images was summarized as the slope of a linear regression. The CBCT slope-features and CT-extracted features were used as input for a Cox proportional hazards model. Moreover, prognostic performance of clinical parameters was investigated for overall survival and locoregional recurrence. Model performances were assessed using the Kaplan-Meier curves and c-index. Results: The radiomics model contained only CT-derived features and reached a c-index of 0.63 for overall survival and could be validated on the first validation dataset. No model for locoregional recurrence could be developed that validated on the validation datasets. The clinical parameters model could not be validated for either overall survival or locoregional recurrence. Conclusion: In this study we could not confirm our hypothesis that longitudinal CBCT-extracted radiomic features contribute to improved prognostic information. Moreover, performance of baseline radiomic features or clinical parameters was poor, probably affected by heterogeneity within and between datasets. (C) 2019 The Authors. Published by Elsevier B. V. Radiotherapy and Oncology 136 (2019) 78-85 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据